1. Comparison of droplet digital PCR and conventional quantitative PCR for measuring EGFR gene mutation
   BO ZHANG et al, 2015, Experimental and Therapeutic Medicine CrossRef
2. Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery
   Jérôme Alexandre Denis et al, 2016, Molecular Oncology CrossRef
3. Colorectal cancer: using blood samples and tumor tissue to detectK-rasmutations
   Yang Li et al, 2015, Expert Review of Anticancer Therapy CrossRef
4. Circulating tumor cells in clinical research and monitoring patients with colorectal cancer
   Claudia Burz et al, 2018, Oncotarget CrossRef
5. KRAS mutations by digital PCR in circulating tumor cells isolated from the mesenteric vein are associated with residual disease and overall survival in resected colorectal cancer patients
   Yan Li et al, 2020, International Journal of Colorectal Disease CrossRef
6. Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory,RAS-BRAFwild-type colorectal cancer receiving cetuximab or panitumumab
   Valeria Musella et al, 2015, International Journal of Cancer CrossRef
7. Detection of activated KRAS from cancer patient peripheral blood using a weighted enzymatic chip array
   Ming-Yii Huang et al, 2014, Journal of Translational Medicine CrossRef
8. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow
   Glenn Deng et al, 2014, BMC Cancer CrossRef
9. Mutational Analysis of Circulating Tumor Cells from Colorectal Cancer Patients and Correlation with Primary Tumor Tissue
   Anna Lyberopoulou et al, 2015, PLOS ONE CrossRef
10. Clinical implementation of pharmacogenetics
    Xandra García-González et al, 2016, Drug Metabolism and Personalized Therapy CrossRef